Thomas Lonngren PhD, MRPharmS, FRCP

Thomas is former Executive Director of the European Medicines Agency, EMA (Jan 01-Dec 10) and previously served with the Swedish Board of Health and Welfare as Director of Operations (1978-93) and later Deputy Director General at the Swedish Medical Products Agency (MPA), Lakemedelsverket (Jan 93 – Dec 00). Thomas established the EMA from a relatively small unknown agency in 2001 to a world-renowned leader in 2010 and was responsible for all of its operations and annual work flow.

He is currently Director at his own independent consultancy, Pharma Executive Consulting (since Jan 2011) offering strategic advice to the health care and pharmaceutical sector in the area of Health Technology Assessment (HTA) and regulatory affairs. Through his consultancy his main work is as Strategic Advisor at NDA Group AB. Thomas is currently serving on several Advisory Boards and was a board member of CBio Ltd Australia (now Invion Limited) for the year 2011. He is Honorary Member of the Royal Pharmaceutical Society of Great Britain, Honorary Fellow of the Royal College of Physicians, Honorary Doctor of Uppsala University, Sweden and Honorary Doctor of the University of Bath, United Kingdom.